The Lupus Foundation of America will partner with the Foundation for the National Institutes of Health (FNIH) to support a new $230 million, five-year initiative that will accelerate the ability to develop new medicines for lupus and other diverse and complex diseases.
$5 Million for Lupus Research Passes Second Critical Hurdle
Today, the U.S. House of Representatives Appropriations Committee passed the Fiscal Year 2017 Appropriations Act, which includes a $5-million provision for funding a lupus specific research program within the Congressionally Directed Medical Research Program (CDMRP) at the Department of Defense (DoD).
“For more than a decade, we have worked tirelessly to encourage the Congress to provide critical funding for lupus research and today’s vote is the culmination of our efforts, which gained momentum after the formation of the Congressional Lupus Caucus,” said Sandra C. Raymond, President and CEO of the Lupus Foundation of America. “We thank the Congressional Lupus Caucus Co-Chairs – Rep. Thomas J. Rooney (R-FL), Rep. William Keating (D-MA), Rep. Ileana Ros-Lehtinen (R-FL), Rep. Eddie Bernice Johnson (D-TX) – and the entire Caucus for their continued efforts to include a lupus-specific medical research program within this bill.”
The Foundation has testified before the Senate Defense Subcommittee, authoring a white paper – Lupus and the Military, and met with CDMRP officials at Fort Detrick. Most recently, the Foundation worked with the Congressional Lupus Caucus to help secure signatures for a Dear Colleague letter to establish the Lupus Medical Research Program at the DoD. The letter was well-supported garnering 23 signatures from members of Congress.
The next step is for the Senate to approve their version of the bill, and any differences between the House and Senate versions will be reconciled before final passage.
“We look forward to continuing to work toward increasing federal funding for lupus research,” said Raymond.
The research plan identifies and examines opportunities to increase scientific understanding of lupus, which will ultimately lead to safer and more effective treatments and, eventually, curative strategies